NCT06777875

Brief Summary

The goal of this observational study is to investigate whether the A118G single-nucleotide polymorphism (SNP) in the mu-opioid receptor1(OPRM1) and Catechol-O-methyltransferase (COMT) SNPs influence postoperative pain scores in children between the ages of 8 and 18 undergoing orthopedic, abdominal, thoracic, and plastic surgeries. The main question\[s\] it aims to answer \[is\]: Do OPRM1 and COMT SNPs influence postoperative pain scores in children between the ages of 8 and 18 undergoing orthopedic, abdominal, thoracic, and plastic surgeries? Participants will be assessed for their pain scores, sedation level, the amount of postoperative analgesics received, duration of their stay in the post-anesthesia care unit, and toxicity.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Mar 2025Jan 2027

First Submitted

Initial submission to the registry

January 9, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 16, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

March 10, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 13, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 13, 2027

Last Updated

March 18, 2025

Status Verified

March 1, 2025

Enrollment Period

1.8 years

First QC Date

January 9, 2025

Last Update Submit

March 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain scores

    Pain scores measured using the Numerical Rating Scale (NRS) (ranging from 0 to 10, with 0 no pain and 10 worst pain)

    Until discharge from PACU (about 3 hours)

Secondary Outcomes (5)

  • Postoperative sedation

    Until discharge from PACU (about 3 hours)

  • Use of intraoperative and post-operative opioids

    Until discharge from PACU (about 3 hours)

  • Length of post-anesthesia care unit (PACU) stay

    Until discharge from PACU (about 3 hours)

  • Postoperative respiratory depression

    Until discharge from PACU (about 3 hours)

  • Postoperative nausea and vomiting

    Until discharge from PACU (about 3 hours)

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Children between the ages of 8-18 undergoing orthopedic, abdominal, thoracic, and plastic surgeries will be recruited from the American University of Beirut Medical Center (AUBMC).

You may qualify if:

  • All children 8 years to 18 years
  • Undergoing orthopedic, abdominal, thoracic, and plastic surgeries
  • American Society of Anesthesiologists classification (ASA) I-II-III

You may not qualify if:

  • Children with schizoid personality disorders, phobias, and anxiety
  • Patients with neuropathic pain associated with surgeries requiring surgical treatment.
  • Children presented with all types of depressive disorders, atypical bipolar disorder, or a suspicion of substance abuse.
  • American Society of Anesthesiologists classification (ASA) ≥IV
  • All patients receiving regional anesthesia, local blocks, epidural and caudal blocks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Roland Kaddoum

Beirut, Lebanon

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Venous whole blood (2 mL) will be sampled into coded Ethylenediaminetetraacetic acid (EDTA) tubes at the time of study enrollment and stored at -80°C. Samples will be obtained during the insertion of the IV in preparation for anesthesia or as left over from blood withdrawn for complete blood count (CBC) in an EDTA purple tube. Genomic DNA will be purified from each blood using a Qiagen kit according to the manufacturer's instructions. Four Catechol-O-methyltransferase (COMT) single-nucleotide polymorphisms (SNPs) (rs6269, rs4633, rs4818, rs4680 and the rs179971 variant.).

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Roland Kaddoum, MD

    American University of Beirut Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Roland Kaddoum, MD

CONTACT

Thouraya HajAli

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 9, 2025

First Posted

January 16, 2025

Study Start

March 10, 2025

Primary Completion (Estimated)

January 13, 2027

Study Completion (Estimated)

January 13, 2027

Last Updated

March 18, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations